Ethema Health (GRST) Stock Price, News & Analysis

Company Overview

Ethema Health, trading under the ticker OTCMKTS:GRST, is a digital health company specializing in remote patient monitoring, telemedicine solutions and AI-driven care coordination. The company develops and operates a secure telehealth platform that integrates medical-grade wearable sensors, mobile applications and cloud-based analytics. Ethema Health’s solutions are designed to improve patient outcomes and reduce hospital readmissions by enabling continuous monitoring of chronic conditions such as heart failure, diabetes and respiratory illnesses.

Ethema Health’s core products include a remote monitoring hub, which aggregates biometric data from connected devices, and a clinician dashboard that provides real-time alerts and trend analysis. The platform also offers patient engagement tools such as symptom questionnaires, medication reminders and secure video conferencing. By combining automated risk stratification algorithms with personalized care plans, Ethema Health aims to support value-based care models and enhance collaboration among healthcare providers, payers and patients.

Founded in 2015, Ethema Health has evolved from a traditional medical device supplier into an end-to-end digital health services company. The management team is led by CEO Dr. Alexandra Stanton, a veteran in health technology innovation, and CFO Marcus Lee, who brings experience in scaling healthcare startups. The company has established strategic partnerships with leading hospital systems, academic research centers and telehealth networks to validate its technology and expand its service offerings.

Headquartered in San Francisco, California, Ethema Health serves clients across North America, Europe and Asia-Pacific. The company is actively pursuing growth through integration with electronic health record (EHR) platforms and collaboration with regional telemedicine providers. With an emphasis on regulatory compliance, data security and interoperability, Ethema Health continues to position itself at the forefront of the shift toward virtual care delivery and population health management.

Key Stats

• Today's Range: $0.0003 to $0.0004
• 50-Day Range: N/A
• 52-Week Range: $0.0002 to $0.0010
• Volume: 21.56 million shs
• Average Volume: 2.62 million shs
• Market Capitalization: $2.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GRST Stock Analysis - Frequently Asked Questions

How have GRST shares performed this year?

Ethema Health's stock was trading at $0.0007 at the beginning of 2025. Since then, GRST shares have decreased by 57.1% and is now trading at $0.0003.

How do I buy shares of Ethema Health?

Shares of GRST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ethema Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ethema Health investors own include Hemp (HEMP), Viva Entertainment Group (OTTV), NOHO (DRNK), HempAmericana (HMPQ), Ifan Financial (IFAN), Marijuana Company of America (MCOA) and Meta Platforms (META).

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:GRST
• CIK: 792935
• Web: ethemahealth.com
• Phone: (416) 500-0020
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.06 million
• Net Margins: -1.03%
• Pretax Margin: -36.00%
• Return on Equity: N/A
• Return on Assets: -0.51%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: $6.02 million
• Price / Sales: 0.39
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,726,280,000
• Free Float: 3,418,881,000
• Market Cap: $2.32 million
• Optionable: Not Optionable
• Beta: 1.78